Our research began by identifying a significant upregulation of EFTUD2 in 5-FU-resistant colorectal cancer tissues, and subsequent Gene Set Enrichment Analysis (GSEA) indicated its association with chemotherapy-resistant phenotypes (Fig. S1). This evidence concerns the gene EFTUD2 and colorectal cancer.